Lu Y - Search Results

1

Identification of a prognostic metabolic gene signature in diffuse large B-cell lymphoma.

Wang H, Shao R, Liu W, Tang H, Lu Y. Wang H, et al. Among authors: lu y. J Cell Mol Med. 2021 Jul;25(14):7066-7077. doi: 10.1111/jcmm.16720. Epub 2021 Jun 14. J Cell Mol Med. 2021. PMID: 34128320 Free PMC article.

2

Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.

Wang L, Liu P, Chen X, Geng Q, Lu Y. Wang L, et al. Among authors: lu y. Med Oncol. 2012 Sep;29(3):2153-8. doi: 10.1007/s12032-011-0049-z. Epub 2011 Aug 30. Med Oncol. 2012. PMID: 21877195

3

Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL): a predictive biomarker for treatment efficacy and valuable prognostic factor.

Wang L, Liao DZ, Zhang J, Xia ZJ, Peng XW, Lu Y. Wang L, et al. Among authors: lu y. Med Oncol. 2013 Dec;30(4):723. doi: 10.1007/s12032-013-0723-4. Epub 2013 Sep 15. Med Oncol. 2013. PMID: 24037346

4

Lymphopenia during routine follow-up may predict relapse in patients with extranodal NK/T cell lymphoma.

Wang L, Wang JH, Wu-Xiao ZJ, Xia ZJ, Huang HQ, Lu Y. Wang L, et al. Among authors: lu y. Tumour Biol. 2015 Mar;36(3):1747-53. doi: 10.1007/s13277-014-2776-1. Epub 2014 Oct 31. Tumour Biol. 2015. PMID: 25366140

5

Increased serum levels of interleukin-15 correlate with negative prognostic factors in extranodal NK/T cell lymphoma.

Wang H, Zhu JY, Liu CC, Zhu MY, Wang JH, Geng QR, Lu Y. Wang H, et al. Among authors: lu y. Med Oncol. 2015 Jan;32(1):370. doi: 10.1007/s12032-014-0370-4. Epub 2014 Nov 27. Med Oncol. 2015. PMID: 25428383

6

A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.

Wang L, Xia ZJ, Lu Y, Wang QX, Niu SQ, Huang HQ, Zhang YJ. Wang L, et al. Among authors: lu y. Leuk Lymphoma. 2015;56(11):3038-44. doi: 10.3109/10428194.2015.1026817. Epub 2015 Mar 28. Leuk Lymphoma. 2015. PMID: 25747971

7

High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.

Wang H, Wang L, Liu WJ, Xia ZJ, Huang HQ, Jiang WQ, Li ZM, Lu Y. Wang H, et al. Among authors: lu y. Oncotarget. 2016 May 31;7(22):33035-45. doi: 10.18632/oncotarget.8847. Oncotarget. 2016. PMID: 27105512 Free PMC article.

8

The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study.

Zhu J, Wang H, Liu CC, Lu Y, Tang H. Zhu J, et al. Among authors: lu y. J Cancer Res Clin Oncol. 2016 Nov;142(11):2339-45. doi: 10.1007/s00432-016-2228-y. Epub 2016 Aug 26. J Cancer Res Clin Oncol. 2016. PMID: 27566683

9

Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study.

Liu WJ, Wang H, Wang WD, Zhu MY, Liu CC, Wang JH, Lu Y. Liu WJ, et al. Among authors: lu y. Sci Rep. 2016 Dec 21;6:39463. doi: 10.1038/srep39463. Sci Rep. 2016. PMID: 28000713 Free PMC article.

10

High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.

Wang L, Wang JH, Liu WJ, Wang WD, Wang H, Chen XQ, Geng QR, Lu Y, Xia ZJ. Wang L, et al. Among authors: lu y. Ann Hematol. 2017 Dec;96(12):2079-2088. doi: 10.1007/s00277-017-3125-4. Epub 2017 Sep 5. Ann Hematol. 2017. PMID: 28871325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,208 results

Search Page

Filters